Quest Diagnostics Incorporated Total Liabilities
Quest Diagnostics Incorporated total liabilities. Based on the latest financial reports, Quest Diagnostics Incorporated (DGX) has total liabilities worth $9.12 Billion USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check DGX financial resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Quest Diagnostics Incorporated (1996–2025)
Total liabilities of Quest Diagnostics Incorporated from 1996 to 2025. This chart illustrates how Quest Diagnostics Incorporated's total liabilities have evolved over time, based on quarterly financial data. Explore DGX long-term investments to assets to see how much of total assets are deployed in long-term investments.
Quest Diagnostics Incorporated Competitors by Total Liabilities
The table below lists competitors of Quest Diagnostics Incorporated ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kia Corp
KO:000270
|
Korea | ₩42.14 Trillion |
|
Ecopetrol S.A
F:ECHA
|
Germany | €184.86 Trillion |
|
Hershey Co
NYSE:HSY
|
USA | $9.11 Billion |
|
China Hongqiao Group Ltd
F:H0Q
|
Germany | €103.67 Billion |
|
InterContinental Hotels Group PLC
LSE:IHG
|
UK | $8.07 Billion |
|
Global Unichip Corp
TW:3443
|
Taiwan | NT$23.92 Billion |
|
CenterPoint Energy Inc
NYSE:CNP
|
USA | $36.53 Billion |
|
Power Grid Corporation of India Limited
NSE:POWERGRID
|
India | Rs-1.00 Trillion |
Liability Composition Analysis (1996–2025)
This chart breaks down Quest Diagnostics Incorporated's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Quest Diagnostics Incorporated (DGX) total assets.
Liquidity & Leverage Metrics
Quest Diagnostics Incorporated Total Liabilities Ratios Explained
Quest Diagnostics Incorporated total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.59 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.21 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.54 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Quest Diagnostics Incorporated's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Quest Diagnostics Incorporated (1996–2025)
The table below shows the annual total liabilities of Quest Diagnostics Incorporated from 1996 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $8.94 Billion | -3.44% |
| 2024-12-31 | $9.26 Billion | +21.74% |
| 2023-12-31 | $7.60 Billion | +11.33% |
| 2022-12-31 | $6.83 Billion | -3.11% |
| 2021-12-31 | $7.05 Billion | -1.21% |
| 2020-12-31 | $7.13 Billion | +0.78% |
| 2019-12-31 | $7.08 Billion | +25.11% |
| 2018-12-31 | $5.66 Billion | +3.49% |
| 2017-12-31 | $5.47 Billion | +1.96% |
| 2016-12-31 | $5.36 Billion | +3.55% |
| 2015-12-31 | $5.18 Billion | -6.63% |
| 2014-12-31 | $5.55 Billion | +11.50% |
| 2013-12-31 | $4.97 Billion | -2.41% |
| 2012-12-31 | $5.10 Billion | -8.94% |
| 2011-12-31 | $5.60 Billion | +25.14% |
| 2010-12-31 | $4.47 Billion | -1.73% |
| 2009-12-31 | $4.55 Billion | -5.14% |
| 2008-12-31 | $4.80 Billion | -8.44% |
| 2007-12-31 | $5.24 Billion | +98.37% |
| 2006-12-31 | $2.64 Billion | +3.90% |
| 2005-12-31 | $2.54 Billion | +32.79% |
| 2004-12-31 | $1.92 Billion | +0.44% |
| 2003-12-31 | $1.91 Billion | +22.59% |
| 2002-12-31 | $1.56 Billion | -2.46% |
| 2001-12-31 | $1.59 Billion | -13.00% |
| 2000-12-31 | $1.83 Billion | -9.06% |
| 1999-12-31 | $2.02 Billion | +154.37% |
| 1998-12-31 | $792.30 Million | -7.79% |
| 1997-12-31 | $859.20 Million | +0.33% |
| 1996-12-31 | $856.35 Million | -- |
About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagn… Read more